DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20180719

Role of PETCT in the management of untreated advanced squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx

Angshuman Dutta, B. G. Chaithra, Harkirat Singh

Abstract


Background: Advanced stage cancers of the oral cavity, oropharynx and hypopharynx have the worst prognosis owing to higher incidence of regional and distant metastases. PET/CT scan can detect distant metastases and can therefore be done at the initial presentation in advanced stage head and neck cancers to facilitate the chalking out of an appropriate treatment plan.

Methods: The study included 41 patients having stage III & IV of oral cavity, oropharyngeal and hypopharyngeal squamous cancer. The patients underwent clinical examination, an initial imaging with CT/MRI of the disease site and conventional metastatic workup. An initial TNM staging and treatment plan was formulated. The patients then underwent PET/CT. Tumor restaging was done and the treatment plan was altered if required after the PETCT.  

Results: There was change in management of 4(9%) owing to upstaging of disease following PETCT.

Conclusions: PETCT scan had a significant impact on the staging of disease affecting change in the treatment protocols. 


Keywords


Positron emission tomography, Cancer, Staging

Full Text:

PDF

References


Trivedi N, Kekatpure V, Kuriakose M. Head and neck cancer in India: Need to formulate uniform national treatment guideline? Indian J Cancer. 2012;49 (1):6.

Gregoire V, Lefebvre J-L, Licitra L, Felip E, On behalf of the EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncol. 2010;21(Supplement 5):v184–6.

Nair S, Mohan S, Nilakantan A, Gupta A, Malik A, Gupta A. Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan on Initial Evaluation of Head and Neck Squamous Cell Carcinoma: Our Experience at a Tertiary Care Center in India. World J Nucl Med. 2015;14(1):19–24.

Lindberg R. Treatment of cervical lymph node metastases from lesions of oropharynx, supraglottis, larynx and hypopharynx. Am J Roentgenal Nucl Med. 1968;102(1):132-7.

Ellis ER, Mendenhall WM, Rao PV, Parsons JT, Spangler AE, Million RR. Does node location affect the incidence of distant metastases in head and neck squamous cell carcinoma? International Journal of Radiation Oncology Biology Physics. 1989;17(2):293–7.

Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1977;40(1):145–51.

Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K et al. Impact of FDGPET/CT imaging on nodal staging for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2007;68:377-82.

Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W,et al. The role of positron emission tomography and computed tomography fusion in the management of early stage and advanced stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:12-6.

Patrick KH, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, et al. The Role of Positron Emission Tomography and Computrd Tomography Fusion in the Mangement of Early- stage and Advanced – stage primary Head and Neck Carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:12–6.

Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron Emission Tomography With [18F] Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter prospective study J Clin Oncol. 2010;28(7):1190-5.

Li X, Di B, Shang Y, Zhou Y, Cheng J, He Z. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. European Journal of Surgical Oncology. 2009;35(12):1348–53.

Fleming AJ, Smith SP, Paul CM, Hall NC, Daly BT, Agrawal A, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/ computed tomography on previously untreated head and neck cancer patients. Laryngoscope. 2007;117(7):1173–9.

Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg. 2007;137(1):130–7.